Their results indicate that during physiological pregnancy, maternal GLP-1 may be involved in mechanisms that compensate for pregnancy-related increases in glycemia and insulin resistance, suggesting a role for this peptide in maternal metabolism and body weight, as well as in fetal growth [38]. This evidence concerns the gene GCG and Insulin resistance.